MNTA Momenta Pharmaceuticals Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Momenta Pharmaceuticals, Inc., and Encourages Investors to Contact the Firm

Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Momenta Pharmaceuticals, Inc. (“Momenta” or the “Company”) (Nasdaq: MNTA) concerning possible violations of federal securities laws.

If you purchased shares of Momenta and want more information free of charge, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at [email protected].

On February 17, 2017, Momenta revealed that a contracted Pfizer facility used to manufacture the Company's Glatopa product was sent a warning letter from the U.S. Food and Drug Administration ("FDA"). Momenta's Abbreviated New Drug Application for its Glatopa 40 mg product candidate is under regulatory review, and under FDA policy, final approval depends on the outcome of the compliance observations at the Pfizer manufacturing facility.

On February 20, 2017, a Leerink Capital Partners LLC analyst stated that the FDA warning letter raises concerns for the Company, as manufacturing warning letters can take years to fix, and that a lengthy delay could weaken Momenta's market opportunity for Glatopa.

When this information was revealed to investors, the value of Momenta fell, causing investors serious harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at [email protected].

This press release may constitute Attorney Advertising in some jurisdictions.

EN
22/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Momenta Pharmaceuticals Inc.

Increased risk weighs on MOMENTA PHARMACEUTICALS, penalising its rati...

The independent financial analyst theScreener just lowered the general evaluation of MOMENTA PHARMACEUTICALS (US), active in the Biotechnology industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date August 11, 2020, the c...

Momenta Pharmaceuticals Inc: 2 directors sold after exercising options...

Two Directors at Momenta Pharmaceuticals Inc sold after exercising options/sold 59,605 shares at between 32.250USD and 32.760USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trade...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

W WAYFAIR INC.
DXCM DEXCOM INC.
SHOP SHOPIFY INC.
INCY INCYTE CORP
RGLD ROYAL GOLD INC
NEM NEWMONT CORPORATION
VEEV VEEVA SYSTEMS INC CLASS A
QRVO QORVO INC.
NUE NUCOR CORPORATION
NOW SERVICENOW INC.
MASI MASIMO CORPORATION
ZBRA ZEBRA TECHNOLOGIES CORPORATION CLASS A
TSCO TRACTOR SUPPLY COMPANY
TECH BIO-TECHNE CORPORATION
TEAM ATLASSIAN CORP. PLC CLASS A
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFM SPROUTS FARMERS MARKETS INC.
RP REALPAGE INC.
ROK ROCKWELL AUTOMATION INC.
PZZA PAPA JOHN'S INTERNATIONAL INC.
PYPL PAYPAL HOLDINGS INC
PRLB PROTO LABS INC.
NERV MINERVA NEUROSCIENCES
MSCI MSCI INC. CLASS A
MPWR MONOLITHIC POWER SYSTEMS INC.
MOH MOLINA HEALTHCARE INC.
MNTA MOMENTA PHARMACEUTICALS INC.
MKTX MARKETAXESS HOLDINGS INC.
LMNX LUMINEX CORP
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
HALO HALOZYME THERAPEUTICS INC.
GFI GOLD FIELDS LTD. ADS
FFIV F5 NETWORKS INC.
ETSY ETSY INC.
ELMD ELECTROMED
EBS EMERGENT BIOSOLUTIONS INC.
EBAY EBAY INC.
CYTK CYTOKINETICS INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
CTLT CATALENT INC
CIEN CIENA CORPORATION
CHMA CHIASMA
CHGG CHEGG INC.
CDNA CAREDX INC
VPA1 AVEO PHARMACEUTICALS INC.
AUDC AUDIOCODES LTD.
AU ANGLOGOLD ASHANTI LTD. ADS
AKBA AKEBIA THERAPEUTICS INC.
AGI. ALAMOS GOLD INC.
ADVM ADVERUM BIOTECHNOLOGIES
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
K. KINROSS GOLD CORPORATION
CCO. CAMECO CORPORATION
SWKS SKYWORKS SOLUTIONS INC.
MAG. MAG SILVER CORP.
AEM. AGNICO EAGLE MINES LIMITED
ELA ELAND OIL & GAS
FREJA VERISEC AB
BIO BIO-RAD LABORATORIES INC. CLASS A
EA ELECTRONIC ARTS INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
MRTN MARTEN TRANSPORT LTD.
ODFL OLD DOMINION FREIGHT LINE INC.
SAM BOSTON BEER COMPANY INC. CLASS A
TREX TREX COMPANY INC.
WERN WERNER ENTERPRISES INC.
MTSI MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC.
WMK WEIS MARKETS INC.
RVP RETRACTABLE TECHNOLOGIES INC.
CC CHEMOURS CO.
FLWS 1-800-FLOWERS.COM CL A
X UNITED STATES STEEL CORPORATION
COUP COUPA SOFTWARE INC.
SNDX SYNDAX PHARMACEUTICALS
KNSL KINSALE CAPITAL GROUP INC.
CDXC CHROMADEX CORP
IRTC IRHYTHM TECHNOLOGIES INC.
SPGI S&P GLOBAL INC.
SSRM SSR MINING INC
SPRO SPERO THERAPEUTICS
SE SEA ADS
BAND BANDWIDTH CLASS A
SIGA SIGA TECHNOLOGIES INC.
SMAR SMARTSHEET
AZN ASTRAZENECA PLC ADS
DOCU DOCUSIGN INC.
DUBA DRDGOLD LTD. ADS
SCPL SCIPLAY
AVTR AVANTOR INC.
VAPO VAPOTHERM
GNMSY GENMAB A/S
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
ZYXI ZYNEX
CGEN COMPUGEN LTD.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch